Melvin Silberklang

1.6k total citations · 1 hit paper
25 papers, 1.4k citations indexed

About

Melvin Silberklang is a scholar working on Molecular Biology, Biotechnology and Epidemiology. According to data from OpenAlex, Melvin Silberklang has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 4 papers in Biotechnology and 3 papers in Epidemiology. Recurrent topics in Melvin Silberklang's work include Viral Infectious Diseases and Gene Expression in Insects (8 papers), RNA and protein synthesis mechanisms (7 papers) and RNA modifications and cancer (6 papers). Melvin Silberklang is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (8 papers), RNA and protein synthesis mechanisms (7 papers) and RNA modifications and cancer (6 papers). Melvin Silberklang collaborates with scholars based in United States, Switzerland and Canada. Melvin Silberklang's co-authors include Uttam L. RajBhandary, Amanda M. Gillum, Anne‐Lise Haenni, Alain Prochiantz, Hans A. Hosbach, Brian J. McCarthy, David E. Eisenbud, Ronald W. Ellis, A. B. Lenny and David K. Robinson and has published in prestigious journals such as Cell, Nucleic Acids Research and The Journal of Immunology.

In The Last Decade

Melvin Silberklang

25 papers receiving 1.3k citations

Hit Papers

[3] Use of in Vitro32P labeling in the sequence analysis ... 1979 2026 1994 2010 1979 100 200 300 400

Peers

Melvin Silberklang
Motohiro Fuke United States
Harvey E. Faber United States
Cha-Mer Wei United States
Jill Gough Australia
Deborah W. Cowing United States
S Broome United States
A. Garapin France
Elizabeth Diblasio United States
Motohiro Fuke United States
Melvin Silberklang
Citations per year, relative to Melvin Silberklang Melvin Silberklang (= 1×) peers Motohiro Fuke

Countries citing papers authored by Melvin Silberklang

Since Specialization
Citations

This map shows the geographic impact of Melvin Silberklang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melvin Silberklang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melvin Silberklang more than expected).

Fields of papers citing papers by Melvin Silberklang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melvin Silberklang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melvin Silberklang. The network helps show where Melvin Silberklang may publish in the future.

Co-authorship network of co-authors of Melvin Silberklang

This figure shows the co-authorship network connecting the top 25 collaborators of Melvin Silberklang. A scholar is included among the top collaborators of Melvin Silberklang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melvin Silberklang. Melvin Silberklang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marx, Gerard, et al.. (2007). Haptide‐coated collagen sponge as a bioactive matrix for tissue regeneration. Journal of Biomedical Materials Research Part B Applied Biomaterials. 84B(2). 571–583. 8 indexed citations
2.
Muthukumar, G, et al.. (2000). Rational scale-up of a baculovirus-insect cell batch process based on medium nutritional depth. Biotechnology and Bioengineering. 52(6). 696–706. 26 indexed citations
3.
Silberklang, Melvin, et al.. (1996). Rapid, High-Level Transient Expression of Papillomavirus-Like Particles in Insect Cells. BioTechniques. 20(5). 890–895. 5 indexed citations
4.
Muthukumar, G, et al.. (1996). Rational scale‐up of a baculovirus‐insect cell batch process based on medium nutritional depth. Biotechnology and Bioengineering. 52(6). 696–706. 18 indexed citations
5.
Robinson, David K., Sandra L. Gould, C. P. Chan, et al.. (1994). Optimization of a Fed‐batch Process for Production of a Recombinant Antibody. Annals of the New York Academy of Sciences. 745(1). 285–296. 19 indexed citations
6.
Gould, Sandra L., et al.. (1994). Use of Lipid Emulsions as Nutritional Supplements in Mammalian Cell Culture. Annals of the New York Academy of Sciences. 745(1). 240–243. 8 indexed citations
7.
Robinson, David K., Chao‐Wu Yu, P.K. Tsai, et al.. (1994). Characterization of a recombinant antibody produced in the course of a high yield fed‐batch process. Biotechnology and Bioengineering. 44(6). 727–735. 52 indexed citations
8.
Ip, Charlotte C. Yu, William J. Miller, Melvin Silberklang, et al.. (1994). Structural Characterization of the N-Glycans of a Humanized Anti-CD18 Murine Immunoglobulin G. Archives of Biochemistry and Biophysics. 308(2). 387–399. 24 indexed citations
9.
Nguyen, Michelle, Soi Cheng Law, Martin Poe, et al.. (1992). Transfection of mouse cytotoxic T lymphocyte with an antisense granzyme A vector reduces lytic activity. The Journal of Immunology. 149(12). 4009–4015. 33 indexed citations
10.
Junker, Beth, Fangzhou Wu, Julie A. Waterbury, et al.. (1992). Evaluation of a microcarrier process for large-scale cultivation of attenuated hepatitis A. Cytotechnology. 9(1-3). 173–187. 13 indexed citations
11.
Tung, Jwu‐Sheng, Christopher T. Dunwiddie, A. B. Lenny, et al.. (1991). Expression and characterization of the N-terminal half of antistasin, an anticoagulant protein derived from the leech Haementeria officinalis. Protein Expression and Purification. 2(1). 37–42. 7 indexed citations
12.
Emini, Emilio A., et al.. (1989). Vero cell‐expressed Epstein‐Barr virus (EBV) gp350/220 protects marmosets from EBV challenge. Journal of Medical Virology. 27(2). 120–123. 23 indexed citations
13.
Han, Jang H., S W Law, Paul M. Keller, et al.. (1989). Cloning and expression of cDNA encoding antistasin, a leech-derived protein having anti-coagulant and anti-metastatic properties. Gene. 75(1). 47–57. 39 indexed citations
14.
Emini, Emilio A., Melvin Silberklang, Loren D. Schultz, et al.. (1988). Antigenic analysis of the epstein-barr virus major membrane antigen (gp350/220) expressed in yeast and mammalian cells: Implications for the development of a subunit vaccine. Virology. 166(2). 387–393. 31 indexed citations
15.
Silberklang, Melvin, et al.. (1983). Chemical reactivity ofE. coli5S RNAin situin the 50S ribosomal subunit. Nucleic Acids Research. 11(3). 605–617. 13 indexed citations
16.
Hosbach, Hans A., Melvin Silberklang, & Brian J. McCarthy. (1980). Evolution of a D. melanogaster glutamate tRNA gene cluster. Cell. 21(1). 169–178. 48 indexed citations
17.
Kunkel, Louis M., Melvin Silberklang, & Brian J. McCarthy. (1979). A third restriction endonuclease from Xanthomonas malvacearum. Journal of Molecular Biology. 132(1). 133–139. 15 indexed citations
18.
Silberklang, Melvin, Amanda M. Gillum, & Uttam L. RajBhandary. (1979). [3] Use of in Vitro32P labeling in the sequence analysis of nonradioactive tRNAs. Methods in enzymology on CD-ROM/Methods in enzymology. 59. 58–109. 419 indexed citations breakdown →
19.
Silberklang, Melvin, Amanda M. Gillum, & Uttam L. RajBhandary. (1977). The use of nuclease P1in sequence analysis of end group labeled RNA. Nucleic Acids Research. 4(12). 4091–4108. 215 indexed citations
20.
Silberklang, Melvin, Alain Prochiantz, Anne‐Lise Haenni, & Uttam L. RajBhandary. (1977). Studies on the Sequence of the 3′‐Terminal Region of Turnip‐Yellow‐Mosaic‐Virus RNA. European Journal of Biochemistry. 72(3). 465–478. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026